Avid Bioservices Stock Beta
| CDMO Stock | USD 12.49 0.01 0.08% |
Avid Bioservices fundamentals help investors to digest information that contributes to Avid Bioservices' financial success or failures. It also enables traders to predict the movement of Avid Stock. The fundamental analysis module provides a way to measure Avid Bioservices' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avid Bioservices stock.
Avid |
Avid Bioservices Company Beta Analysis
Avid Bioservices' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Avid Bioservices Beta | 1.41 |
Most of Avid Bioservices' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avid Bioservices is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Avid Bioservices has a Beta of 1.405. This is 63.37% higher than that of the Biotechnology sector and about the same as Health Care (which currently averages 1.39) industry. The beta for all United States stocks is notably lower than that of the firm.
Avid Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avid Bioservices' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avid Bioservices could also be used in its relative valuation, which is a method of valuing Avid Bioservices by comparing valuation metrics of similar companies.Avid Bioservices is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Avid Bioservices will likely underperform.
Avid Fundamentals
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 | ||||
| Profit Margin | (1.01) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 971.01 M | ||||
| Shares Outstanding | 63.96 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 98.87 % | ||||
| Number Of Shares Shorted | 11.62 M | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 17.83 X | ||||
| Price To Sales | 5.61 X | ||||
| Revenue | 139.91 M | ||||
| Gross Profit | 8.93 M | ||||
| EBITDA | (11.48 M) | ||||
| Net Income | (140.75 M) | ||||
| Cash And Equivalents | 115.14 M | ||||
| Cash Per Share | 1.85 X | ||||
| Total Debt | 207.83 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 1.93 X | ||||
| Book Value Per Share | 0.96 X | ||||
| Cash Flow From Operations | 10.95 M | ||||
| Short Ratio | 3.19 X | ||||
| Earnings Per Share | (2.41) X | ||||
| Price To Earnings To Growth | 16.30 X | ||||
| Target Price | 12.5 | ||||
| Number Of Employees | 371 | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 798.9 M | ||||
| Total Asset | 336.56 M | ||||
| Retained Earnings | (571.87 M) | ||||
| Working Capital | 33.44 M | ||||
| Current Asset | 25.65 M | ||||
| Current Liabilities | 10.9 M | ||||
| Net Asset | 336.56 M |
About Avid Bioservices Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avid Bioservices's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avid Bioservices using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avid Bioservices based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving against Avid Stock
| 0.51 | MBRX | Moleculin Biotech | PairCorr |
| 0.49 | MDXG | MiMedx Group | PairCorr |
| 0.41 | VANI | Vivani Medical | PairCorr |
| 0.37 | MBIO | Mustang Bio | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Avid Bioservices Piotroski F Score and Avid Bioservices Altman Z Score analysis. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.